- Benzinga•3 hours agoAllergan Gets Positive Opinion For Its Truberzi For Irritable Bowel Syndrome With Diarrhoea Treatment In Adults
Allergan plc (NYSE: AGN ) revealed that the Committee for Medicinal Products for Human Use (CHMP) has adopted a favorable Opinion for its TRUBERZI in the European Union. According to the company, TRUBERZI ...
After hours: 247.850.00 (0.00%) as of 4:00 PM EDT
|Bid||247.93 x 300|
|Ask||247.96 x 200|
|52wk Range||195.50 - 340.34|
|Day's Range||246.09 - 250.29|
|Avg Vol (3m)||3,574,328|
As of 4:00 PM EDT. Market closed.